TCF7L1 and cervical cancer: The rs11904127 of TCF7L1 significantly decreased cervical cancer risk under allele model (A vs. G, OR 0.79, p = 0.010), codominant model (GA vs. GG, OR 0.68, p = 0.006; AA vs. GG, OR 0.67, p = 0.043), dominant model (GA-AA vs. GG, OR 0.68, p = 0.003), and Log-additive model (OR 0.79, p = 0.010).